Trial · NCT00968812
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in HbA1c From Baseline to Week 52 | Canagliflozin 100 mg | -0.82 | Standard Error 0.039 | Percent | |
| Change in HbA1c From Baseline to Week 52 | Canagliflozin 300 mg | -0.93 | Standard Error 0.039 | Percent | |
| Change in HbA1c From Baseline to Week 52 | Glimepiride | -0.81 | Standard Error 0.039 | Percent | |
| Percentage of Patients Experiencing at Least 1 Hypoglycemic Event From Baseline to Week 52 | Canagliflozin 100 mg | 5.6 | Percentage of patients | ||
| Percentage of Patients Experiencing at Least 1 Hypoglycemic Event From Baseline to Week 52 | Canagliflozin 300 mg | 4.9 | Percentage of patients | ||
| Percentage of Patients Experiencing at Least 1 Hypoglycemic Event From Baseline to Week 52 | Glimepiride | 34.2 | Percentage of patients | ||
| Percent Change in Body Weight From Baseline to Week 52 | Canagliflozin 100 mg | -4.2 | Standard Error 0.2 | Percent change | |
| Percent Change in Body Weight From Baseline to Week 52 | Canagliflozin 300 mg | -4.7 | Standard Error 0.2 | Percent change | |
| Percent Change in Body Weight From Baseline to Week 52 | Glimepiride | 1.0 | Standard Error 0.2 | Percent change | |
| Change in HbA1c From Baseline to Week 104 | Canagliflozin 100 mg | -0.65 | Standard Error 0.042 | Percent | |
| Change in HbA1c From Baseline to Week 104 | Canagliflozin 300 mg | -0.74 | Standard Error 0.042 | Percent | |
| Change in HbA1c From Baseline to Week 104 | Glimepiride | -0.55 | Standard Error 0.043 | Percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00968812/results